Phinomics is a precision-medicine platform company, focused on exploiting unique circular-DNA targets for precision care and identification of new therapeutics. Firm's discovery is grounded in reproducible science, novel technologies, proprietary workflows, and informatics/AI. Company platform enables rigorous identification of novelpathology-specific circular-DNAs and clinical validation of the previously-hidden targets to address unmet needs with unprecedented resolution.
